FDA Inspection 628500 — Cobrek Pharmaceuticals Inc

Cobrek Pharmaceuticals Inc — FEI 3003461362

The FDA completed an inspection of Cobrek Pharmaceuticals Inc on Nov 16, 2009 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 16, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chicago, IL (United States)